New biomarkers in epithelial ovarian cancer: needed or redundant?

MLA

Stiekema, A., et al. “New Biomarkers in Epithelial Ovarian Cancer: Needed or Redundant?” European Journal of Gynaecological Oncology, vol. 38, no. 3, June 2017, pp. 356–60. EBSCOhost, https://doi.org/10.12892/ejgo3484.2017.

APA

Stiekema, A., Korse, C. M., Aaronson, N. K., van Driel, W. J., Kenter, G. G., & Lok, C. A. R. (2017). New biomarkers in epithelial ovarian cancer: needed or redundant? European Journal of Gynaecological Oncology, 38(3), 356–360. https://doi.org/10.12892/ejgo3484.2017

Chicago

Stiekema, A., C. M. Korse, N. K. Aaronson, W. J. van Driel, G. G. Kenter, and C. A. R. Lok. 2017. “New Biomarkers in Epithelial Ovarian Cancer: Needed or Redundant?” European Journal of Gynaecological Oncology 38 (3): 356–60. doi:10.12892/ejgo3484.2017.